147 Pharmacological characterization of NMS-P506, a novel second generation HSP90 inhibitor
Gianpaolo Fogliatto, Antonella Isacchi(Nerviano Medical Sciences), Laura Gianellini, Mauro Paolucci, Daniele Donati(Nerviano Medical Sciences), Marco Guanci(Nerviano Medical Sciences), Sergio Mantegani, Anna De Ponti(Nerviano Medical Sciences), Enrico Pesenti, Nadia Amboldi(University of Pavia)
Cited by 0
Related Papers
Discovery of drug mode of action and drug repositioning from transcriptional responses
|Proceedings of the National Academy of Sciences|2010|853
Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
|Molecular Cancer Therapeutics|2016|317
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis.
|Proceedings of the National Academy of Sciences|1995|205